International consensus (ICON) on treatment of Meniere's disease

被引:106
|
作者
Nevoux, J. [1 ,2 ]
Barbara, M. [3 ]
Dornhoffer, J. [4 ,5 ]
Gibson, W. [6 ]
Kitahara, T. [7 ]
Darrouzet, V. [8 ]
机构
[1] CHU Bicetre, AP HP, Dept Otol & Neurotol, F-94270 Le Kremlin Bicetre, France
[2] Saclay Univ, Paris Sud Med Sch, F-94270 Le Kremlin Bicetre, France
[3] Sapienza Univ, Dept Otol & Neurotol, Rome, Italy
[4] Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA
[5] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA
[6] Univ Sydney, Dept Otolaryngol Head & Neck Surg, Sydney, NSW, Australia
[7] Nara Med Univ, Dept Otolaryngol, Kashihara, Nara, Japan
[8] Univ Bordeaux, CHU Bordeaux, Dept Otolaryngol, Skull Base Surg, F-33000 Bordeaux, France
基金
日本学术振兴会;
关键词
International consensus; Meniere's disease; Treatment; DOUBLE-BLIND; HIGH-DOSAGE; LONG-TERM; BETAHISTINE; DEXAMETHASONE; GENTAMICIN; MANAGEMENT; DIURETICS; PRESSURE; EFFICACY;
D O I
10.1016/j.anorl.2017.12.006
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To present the international consensus for recommendations for Meniere's disease (MD) treatment. Methods: Based on a literature review and report of 4 experts from 4 continents, the recommendations have been presented during the 21st IFOS congress in Paris, in June 2017 and are presented in this work. Results: The recommendation is to change the lifestyle, to use the vestibular rehabilitation in the intercritic period and to propose psychotherapy. As a conservative medical treatment of first line, the authors recommend to use diuretics and Betahistine or local pressure therapy. When medical treatment fails, the recommendation is to use a second line treatment, which consists in the intratympanic injection of steroids. Then as a third line treatment, depending on the hearing function, could be either the endolymphatic sac surgery (when hearing is worth being preserved) or the intratympanic injection of gentamicin (with higher risks of hearing loss). The very last option is the destructive surgical treatment labyrinthectomy, associated or not to cochlear implantation or vestibular nerve section (when hearing is worth being preserved), which is the most frequent option. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S29 / S32
页数:4
相关论文
共 50 条
  • [11] Intratympanic Dexamethasone in the Treatment of Meniere's Disease: A Comparison of Two Techniques
    Beyea, Jason A.
    Instrum, Ryan S.
    Agrawal, Sumit K.
    Parnes, Lorne S.
    OTOLOGY & NEUROTOLOGY, 2017, 38 (06) : E173 - E178
  • [12] Pressure treatment versus gentamicin for Meniere's disease
    Ödkvist, L
    ACTA OTO-LARYNGOLOGICA, 2001, 121 (02) : 266 - 268
  • [13] Medical treatment of Meniere's disease: A review of literature
    Claes, J
    VandeHeyning, PH
    ACTA OTO-LARYNGOLOGICA, 1997, : 37 - 42
  • [14] Report from a Consensus Conference on the treatment of Meniere's disease with betahistine: rationale, methodology and results
    Casani, A. P.
    Guidetti, G.
    Schoenhuber, R.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2018, 38 (05) : 460 - 467
  • [15] When and how to use gentamicin in the treatment of Meniere's disease
    Odkvist, LM
    Bergenius, J
    Moller, C
    ACTA OTO-LARYNGOLOGICA, 1997, : 54 - 57
  • [16] Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease
    Boleas-Aguirre, Maria Soledad
    Lin, Frank R.
    Della Santina, Charles C.
    Minor, Lloyd B.
    Carey, John P.
    OTOLOGY & NEUROTOLOGY, 2008, 29 (01) : 33 - 38
  • [17] Therapeutic strategies in the treatment of Meniere's disease: the Italian experience
    Quaranta, Nicola
    Picciotti, P.
    Porro, G.
    Sterlicchio, B.
    Danesi, G.
    Petrone, P.
    Libonati, Giacinto Asprella
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (07) : 1943 - 1950
  • [18] Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
    Guan, Yafeng
    Chari, Divya A.
    Liu, Yu-Hsi
    Rauch, Steven D.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [19] Contemporary perspectives on the pathophysiology of Meniere's disease: implications for treatment
    Semaan, Maroun T.
    Megerian, Cliff A.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (05) : 392 - 398
  • [20] Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Meniere's disease
    She, W.
    Lv, L.
    Du, X.
    Li, H.
    Dai, Y.
    Lu, L.
    Ma, X.
    Chen, F.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (03) : 232 - 237